Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Postprandial Lipoprotein Response Study
NCT00101439Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started Nov 2005; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00101439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101439.